BioCentury
ARTICLE | Company News

General Electric, NeoGenomics deal

January 4, 2016 8:00 AM UTC

NeoGenomics completed its acquisition of General Electric’s Clarient Inc. unit and Clarient’s Clarient Diagnostic Services Inc. subsidiary for $80 million in cash, $110 million in preferred stock and...